News

WASHINGTON, DC – October 12, 2020 – deepwatch, a leading provider of intelligence driven managed security services, announced it has closed a $53 million Series B investment led by Goldman Sachs with participation from existing investor, ABS Capital Partners. As part of the investment, Holger Staude, a Managing Director of Goldman Sachs Growth, will join the

BALTIMORE, October 7, 2020 – Today, Audacious Inquiry (Ai), an industry leader in technology-enabled transitions of care, announced the addition of three new executives to its senior leadership team. Aledade Co-Founder Edwin Miller joins the company as Chief Product Officer; former Chief Technology Officer at FranConnect and VP of Engineering at SuccessFactors/SAP, Sunil Chandran, joins

Via the Baltimore Business Journal Baltimore venture capital firm Squadra Ventures is taking steps to make good on its commitment to increase diversity within its investment team — and is bringing other local funders onboard to do the same. Squadra recently added a set of undergraduate interns from two regional historically black colleges and universities

CLEVELAND, OHIO – September 15, 2020 – Accurate Group, a leading provider of technology-driven real estate appraisal, title data, analytics and e-closing solutions, today announced the launch of a bundled solution designed to help credit unions accelerate growth and improve efficiency in real estate lending. Accurate Group provides the digital framework and modernized appraisal, title and

In the August edition of the ABS Capital Monthly Roundup, we highlight members of our portfolio that have been recognized as some of the top private companies in the U.S., as well as some new hires and services!

JOHNSON CITY, Tenn., Sept. 10, 2020 /PRNewswire/ — LabConnect, the preeminent provider of clinical trial central lab services, today announced the expansion of its Johnson City facility to support its significant growth in cell and gene therapy and immuno-oncology studies.  The company, which recently relocated its headquarters to Tennessee, is doubling the capacity of its biorepository for sample storage and its clinical trial